Código QR (código de barras bidimensional)

Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study

Abstract Background Imatinib is the gold standard for the treatment of all phases of Philadelphia positive Chronic Myeloid Leukemia (CML). During treatment, patients may develop cytopenia. We aimed to study the baseline characteristics and factors associated with cytopenia at a Nairobi Hospital. Met...

ver descrição completa

Na minha lista:
Principais autores: Angela McLigeyo, Jamilla Rajab, Peter Oyiro, Mohammed Ezzi, Yatich Bett, Matilda Ong’ondi, Andrew Odhiambo, Sitna Mwanzi, Nicholas Othieno-Abinya
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-02-01
coleção:BMC Cancer
Assuntos:
Imatinib
CML
Cytopenia
Philadelphia
BCR-ABL
Tyrosine Kinase
Acesso em linha:https://doi.org/10.1186/s12885-021-09162-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados